-
1.发明公开公开(公告)号：US20240108726A1
公开(公告)日：2024-04-04
申请号：US18539830
申请日：2023-12-14
IPC分类号： A61K47/02 , A61K9/20 , A61K31/5517 , A61K47/32
CPC分类号： A61K47/02 , A61K9/2009 , A61K9/2027 , A61K9/2077 , A61K31/5517 , A61K47/32
摘要： An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
-
2.发明公开公开(公告)号：US20230330044A1
公开(公告)日：2023-10-19
申请号：US18213524
申请日：2023-06-23
发明人： Ronald L. Leech, JR.
CPC分类号： A61K31/137 , A61K9/2059 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/32 , A61K47/38
摘要： Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
-
公开(公告)号：US11723885B2
公开(公告)日：2023-08-15
申请号：US17521581
申请日：2021-11-08
发明人： Ronald L. Leech, Jr.
CPC分类号： A61K31/137 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/32 , A61K47/38
摘要： Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
-
4.发明申请公开(公告)号：US20170239354A1
公开(公告)日：2017-08-24
申请号：US15588982
申请日：2017-05-08
IPC分类号： A61K47/02 , A61K47/32 , A61K31/5517
CPC分类号： A61K47/02 , A61K9/2009 , A61K9/2027 , A61K9/2077 , A61K31/5517 , A61K47/32
摘要： An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
-
公开(公告)号：US20160199388A1
公开(公告)日：2016-07-14
申请号：US15074458
申请日：2016-03-18
IPC分类号： A61K31/5517 , A61K47/32 , A61K47/02
CPC分类号： A61K47/02 , A61K9/2009 , A61K9/2027 , A61K9/2077 , A61K31/5517 , A61K47/32
摘要： An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
-
6.发明申请EXTENDED RELEASE OPIOID ABUSE DETERRENT COMPOSITIONS AND METHODS OF MAKING SAME 有权延长的释放滥用药物组合物及其制备方法公开(公告)号：US20130171257A1
公开(公告)日：2013-07-04
申请号：US13779071
申请日：2013-02-27
发明人： Vijai Kumar , David Dixon , Divya Tewari , Dilip B. Wadgaonkar
CPC分类号： A61K31/485 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2059 , A61K9/2095 , A61K9/2853 , A61K9/2866 , A61K9/2893 , A61K47/32 , A61K47/34 , A61K47/38
摘要： This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
摘要翻译： 本发明涉及一种阿片类镇痛药的滥用威慑剂型，其中将镇痛有效量的阿片类止痛剂与聚合物组合以形成基质。
-
7.发明申请METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS 审中-公开用于确定药物滥用药物产品的方法和组合物公开(公告)号：US20120202839A1
公开(公告)日：2012-08-09
申请号：US13450102
申请日：2012-04-18
IPC分类号： A61K31/485 , A61P25/04 , A61K47/36
CPC分类号： A61K9/0043 , A61K9/146 , A61K9/1635 , A61K9/1652 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K9/2095 , A61K9/4808 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K9/5026 , A61K9/5078 , A61K9/5084 , A61K31/74 , A61K45/06 , A61K2300/00
摘要： This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose.
摘要翻译： 本发明涉及治疗有效量的任何活性药物的口服剂型的滥用威慑制剂，其可与凝胶形成聚合物，鼻粘膜刺激性表面活性剂和冲洗剂混合使用。 这种剂型旨在通过注射，鼻吸入或消耗超过通常治疗有效剂量的剂量单位的量来阻止活性药物物质的滥用。
-
8.发明授权Methods and compositions for deterring abuse of opioid containing dosage forms 有权用于阻止滥用含阿片样物质的剂型的方法和组合物公开(公告)号：US07201920B2
公开(公告)日：2007-04-10
申请号：US10723654
申请日：2003-11-26
申请人： Vijai Kumar , David Dixon , Divya Tewari , Dilip B. Wadgaonkar
发明人： Vijai Kumar , David Dixon , Divya Tewari , Dilip B. Wadgaonkar
IPC分类号： A61K9/20 , A61K9/48 , A61K31/135 , A61K31/485 , A61K31/4468 , A01N43/647 , A01N43/40 , A01N43/46
CPC分类号： A61K31/485 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2059 , A61K9/2095 , A61K9/2853 , A61K9/2866 , A61K9/2893 , A61K47/32 , A61K47/34 , A61K47/38
摘要： This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
摘要翻译： 本发明涉及一种阿片类镇痛药的滥用威慑剂型，其中将镇痛有效量的阿片类止痛剂与聚合物组合以形成基质。
-
公开(公告)号：US11083794B2
公开(公告)日：2021-08-10
申请号：US16899529
申请日：2020-06-11
IPC分类号： A61K47/02 , A61K47/32 , A61K9/20 , A61K31/5517
摘要： An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
-
10.发明申请公开(公告)号：US20210113542A1
公开(公告)日：2021-04-22
申请号：US16498746
申请日：2018-03-30
IPC分类号： A61K31/451 , A61K47/02 , A61K47/32 , A61K47/36 , A61K47/42 , A61K47/14 , A61K47/12 , A61K47/26 , A61K47/38 , A61K47/46 , A61K45/06 , A61K31/46 , A61K31/485 , A61K31/426 , A61K9/16
摘要： An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.
-
-
-
-
-
-
-
-
-
搜索结果
65 条记录 (耗时 0.022 秒)
